Sio Gene Therapies Inc.

OTCPK:SIOX Stock Report

Market Cap: US$34.8m

Sio Gene Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SIOX?
Owner TypeNumber of SharesOwnership Percentage
Institutions6250.000845%
Individual Insiders88,3530.119%
Public Companies18,577,38025.1%
General Public55,308,83874.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 5 shareholders own 25.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.1%
Roivant Sciences Ltd.
18,577,380US$8.7m0%no data
0.061%
David Nassif
45,244US$21.3k0%no data
0.045%
Atul Pande
33,370US$15.7k0%no data
0.013%
Berndt Axel Modig
9,739US$4.6k0%no data
0.00084%
LLB Invest Kapitalanlagegesellschaft m.b.H.
625US$292.10%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.